Abstract
There is increasing reporting by patients’ organization and researchers of long covid (or post-acute sequelae of SARS-CoV-2 - PASC), characterized by symptoms such as fatigue, dyspnea, chest pain, cognitive and sleeping disturbances, arthralgia and decline in quality of life. Immune system dysregulation with a hyperinflammatory state, direct viral toxicity, endothelial damage and microvascular injury have been proposed as pathologenic mechanisms. Recently, cohorts of children with PASC have been reported in Italy, Sweden and Russia. However, immunological studies of children with PASC have never been performed.
In this study, we documented significant immunologic differences between children that completely recovered from acute infection and those with PASC, providing the first objective laboratory sign of the existence of PASC in children.
Introduction
There is increasing reporting by patients’ organization and researchers of long covid (or post-acute sequelae of SARS-CoV-2 - PASC), characterized by symptoms such as fatigue, dyspnea, chest pain, cognitive and sleeping disturbances, arthralgia and decline in quality of life1. Immune system dysregulation with a hyperinflammatory state, direct viral toxicity, endothelial damage and microvascular injury have been proposed as pathologenic mechanisms1. Recently, cohorts of children with PASC have been reported in Italy2, Sweden3 and Russia4. However, immunological studies of children with PASC have never been performed.
Methods
Children with PASC after microbiologically confirmed (with PCR on nasopharyngeal swab) acute COVID-19 were identified using an internationally-developed survey (https://isaric.org/research/covid-19-clinical-research-resources/paediatric-follow-up/). PASC children were defined as those having persisting symptoms for more than five weeks and involvement of two systems or more. As a control group, we enrolled children that fully recovered from acute COVID-19. Children that fully recovered or with PASC assessed in a dedicated post-covid outpatient service were invited to perform an immunological assessment which included:
- T regulatory and B cells subsets, from freshly collected blood samples, labelled with DuraClone® lyophilized antibody panels and analysed with Kaluza® 2.1 (Beckman Coulter, Pasadena, CA, USA).
- expression levels of cytokines IL6, IL1β and TNFα, using the ELLA system (ProteinSimple, San Jose, California, USA) according to the manufacturer’s protocol.
The study was approved by the ethic committee of our Institution (ID 3078). Written informed consent was obtained from all participants or legal guardians.
Results
We enrolled 12 children with PASC (long covid) and 17 that completely recovered from the acute infection (Table 1).
Distinct immunologic features were detectable comparing PASC patients and children who had recovered. The group of PASC showed significantly higher levels of plasmablasts, IgD-CD27+ memory and switched IgM-IgD- B cells. On the contrary, healed children had significantly higher naïve and unswitched IgM+IgD+ and IgM+CD27-CD38dim B cell subsets (figure 1a). The T-regulatory compartment showed no significant differences (Figure 1b). Moreover, IL6 and IL1β serum levels were elevated in PASC patients and consistently higher than children who had recovered after infection (Figure 1c).
Discussion
While PASC is widely recognized in adults1, its existence in children is more controversial, since it has been speculated that this group may rather have psychological sequelae of social restrictions. In this study, we documented significant immunologic differences between children that completely recovered from acute infection and those with PASC, providing the first objective laboratory sign of the existence of PASC in children. Healed children restored B-cell homeostasis, by reconstituting the naïve/unswitched B-cell compartment. In PASC children, the consistent amounts of plasmablasts, switched and memory B lymphocytes revealed the involvement of those subsets in the immunopathogenesis of chronic symptoms. Moreover, the persisting high levels of IL6 and IL1β suggest that innate immune response played a pivotal role in children with PASC. Considering their role as mediators of inflammatory responses and auto-immune processes, these findings could explain systemic persisting symptoms such as fatigue and post-exertional malaise, headache, muscle and joint pain, and tachycardia.
The possibility that a low level, persistent infection after acute infection may persist in some children, contributing to the development of post-acute inflammatory conditions such as Multisystem Inflammatory Syndrome (MIS-C) or PASC has recently been suggested. The presence of persisting viral particles were recently detected by immune-histochemistry and electron microscopy in dermal vascular endothelium weeks after acute infection5. Moreover, extensive burr cells (echinocytes) have been described in the blood smears of patients with MIS-C (which typically develops weeks after acute infection), and have been linked to inflammatory conditions6. Our findings provide further evidence that a chronic inflammatory process and immune dysfunction may explain why some children develop PASC, highlighting the importance of further studies aimed to better characterize this new condition. A better understating of PASC will also provide indirect benefits for other post-infectious conditions.
Limitations of our study are the low number of children included and the lack of ex-vivo immunologic studies performed after in-vitro stimulation with SARS-CoV-2, which we plan as a future study.
Data Availability
dataset is available upon request to the corresponding author
Footnotes
Funding: nothing to declare
Conflict of interests: nothing to declare
Data statement availability: dataset is available upon request to the corresponding author